Upstream process development CDMO services to maximize your biologics production. Increase yields, reduce costs and validate your processes with our innovative development and characterization solutions.
Upstream process development focuses on optimizing the initial stages of biologics production to maximize yield and quality. Once cell lines have been engineered and optimized, cell culture begins as part of upstream process development. Cells are cultured in bioreactors to produce the biologic of interest. Our upstream process development services include fed-batch cultures or continuous perfusion approaches as per the customer’s needs.
Processing that continues without interruption. We use single-use bioreactors and intensified perfusion to achieve continuous upstream processing and bring you:
We offer continuous processing as part of our upstream process development or our patented and commercially validated fully-connected continuous manufacturing™ platform, EnzeneX™.
Enzene is committed to optimizing your upstream processes to maximize efficiency, productivity and cost-effectiveness. Our team of experts combines cutting-edge technologies with a deep understanding of cell culture and bioprocessing to help you achieve your production goals.
Experience the benefits of our patented FCCM™ platform, featuring single-use bioreactors, intensified perfusion and fully connected processes for high-quality, efficient and scalable production.
Gain valuable insights into your upstream process through detailed analysis of cell lines, culture media and bioreactor conditions, ensuring optimal performance and product quality.
Whether you require the development of a new upstream process or the optimization of an existing one, we offer customized solutions to meet your specific requirements and accelerate your path to market.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.